作者:Mark E. Schnute、John I. Trujillo、Katherine L. Lee、Ray Unwalla、Felix F. Vajdos、Björn Kauppi、Philippe Nuhant、Andrew C. Flick、Kimberly K. Crouse、Yajuan Zhao、Amanda Samuel、Vincent Lombardo、Alexandria P. Taylor、Amy L. Brault、John D. Knafels、Michael L. Vazquez、Gabriel Berstein
DOI:10.1021/acsmedchemlett.2c00500
日期:2023.2.9
Macrocyclic retinoic acid receptor-related orphan receptor C2 (RORC2) inverse agonists have been designed with favorable properties for topical administration. Inspired by the unanticipated bound conformation of an acyclic sulfonamide-based RORC2 ligand from cocrystal structure analysis, macrocyclic linker connections between the halves of the molecule were explored. Further optimization of analogues
大环视黄酸受体相关孤儿受体 C2 (RORC2) 反向激动剂已被设计为具有良好的局部给药特性。受共晶结构分析中无环磺酰胺基 RORC2 配体意外结合构象的启发,探索了分子两半之间的大环连接体连接。对类似物进行了进一步优化,以最大限度地提高效力并完善最适合局部应用的理化特性(分子量、亲脂性)。化合物14能够有效抑制人 Th17 细胞产生白细胞介素 17A (IL-17A),并在体外渗透健康人皮肤,从而在皮肤表皮和真皮层中实现高总化合物浓度。